Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

NCT00705471 · clinicaltrials.gov ↗

TERMINATED

Status

42

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped prematurely due to enrolment challenges.

Conditions

Crohn Disease

Interventions

BIOLOGICAL: Infliximab

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]